Ivon H. G. Tielen

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

Simon A. Joosse, Erik H. van Beers, Ivon H. G. Tielen et al. · Breast Cancer Research and Treatment · 2008 · 162 citations · Full text

Breast Oncology, Medicine, Pathology +5

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

Nico van Zandwijk, Alexandre Mathy, Lucie Boerrigter et al. · Annals of Oncology · 2006 · 150 citations · Full text

Kras Mutations, Medicine, Pathology +8

Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis

Ronald SA de Vreeze, Daphne de Jong, Ivon H. G. Tielen et al. · Modern Pathology · 2008 · 95 citations · Full text

Tumoral Pathology, Surgical Pathology, Histopathology +5

Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience

Ronald S. A. de Vreeze, Daphne de Jong, Petra M. Nederlof et al. · Annals of Surgical Oncology · 2009 · 33 citations · Full text